1Ho TW, Mishu B, Li CY, et al. Guillain-Barre syndrome in northem China:relationship to campylobacter jejuni infection and anti-glycolipid antibodies[ J ]. Brain, 1995,118: 597-605.
2Kuwabara S, Ogawara K, Koga M, et al. Hyperreflexia in Guillain-Barre syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody[J]. J Neurol Neurosurg Psychiatry, 1999, 67:180-184.
3Feasby TE, Gillbert JJ, Brown WF, et al. An acute axonal form of Guil- lain-Barre polyneuropathy[J]. Brain, 1986,109: 1115-1126.
4Guillermo P, Tripoli J, Galicchlo S, et al. Epidemiological, clinical, and electrodiagnostic findings in childood Guillain-Barre syndrome:a reappraisal[J] .Ann Neurol, 1999, 46:701-707.
5Ho TW, Li CY, Cornbhth DR, et al. Patterns of recovery in the Guil- lain-Barre syndrome[J]. Neurology, 1997, 48:695-700.
6Hughes RAC, Newsom-Davis JM, Perkin GD, et al. Controlled trial of prednisolone in acute polyneuropathy[J]. Lancet, 1978, 2:750-753.
7Kuwabara S, Asahina M, Koga M, et al. Two petterns of clinical recovery in Guillain-Barre syndrome with IgG anti-GM1 antibody[J ]. Neurology, 1998, 51:1656-1660.
8Ramos-Alvarez M, Bessudo L, Sabin A. Paralytic syndromes associated with noninflammatory cytoplasmatic or nuclear nauronopathy: acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barre syndrome[J]. JAMA, 1969, 207: 1481- 1492.
9The Italian Guillain-Barre Study Group. The prognosis and main prognostic indicators of Guillain-Barre syndrome. A multicenter prospective study of 297 patients[J]. Brain. 1998,121:767-769.
